Free Newsletter
Scientists create cheaper versions of anti-HIV molecule
Researchers have overcome one of the chief obstacles to developing a vaginal gel to protect poor women from HIV infection. Scientists at Case Western Reserve University have invented cheaper versions of an anti-HIV molecule known as PSC-Rantes, which prevents viral entry into cells. The development should make cheaper gels available.
"We always felt we had something very promising here," said Dr. Michael Lederman, the director of the Case Center for AIDS Research based at University Hospitals. "We have been effectively dealing with those challenges and resolving them. That is what it takes to develop a strategy. When we started this, no one thought this would make any sense."
- read this report
More stories about AIDS
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: